Specialty Pipeline Report Highlights New Cancer Meds

Specialty Pipeline Report Highlights New Cancer Meds

Four new oncology therapies top the list of medications recently approved by the FDA.  Descriptions of these drugs and others up for review in the near future are included in the latest Specialty Pipeline Report, written by Express Scripts’ Aimee Tharaldson, PharmD, senior clinical consultant. 

To better serve our clients, UBC and Accredo work closely with Express Scripts to monitor this report and other drug pipeline updates.  Leveraging this industry insight, we can anticipate market shifts and the needs of manufacturers, their prescribers, and patients. 

Whether we’re putting programs in place to provide Coordinated Care for Cancer Patients , Nursing and Adherence support, or Concierge Specialty Pharmacy services, we’re focused on  the needs of our clients and the information needed to make informed decisions that optimize patient care.